Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada
· Delayed Price · Currency is CAD 0.110
0.00 (0.00%)
At close: Mar 6, 2026
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 11.98 million as of March 6, 2026. Its market cap has decreased by -52.25% in one year.
Market Cap
11.98M
Enterprise Value
11.08M
Revenue
754.64K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 11.98M, an increase of 80.47%. That is a compound annual growth rate of 15.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.98M | 0.04% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovotech | 13.26M |
| Lobe Sciences | 14.82M |
| Rapid Dose Therapeutics | 15.55M |
| Glow Lifetech | 9.08M |
| PreveCeutical Medical | 8.97M |
| Britannia Life Sciences | 16.23M |
| Hemostemix | 16.60M |
| PharmaTher Holdings | 8.65M |